| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |